NeoTract Designates Dr. Michael Belsante as UroLift® Center of Excellence
Teleflex Incorporated (TFX)
Last teleflex incorporated earnings: 4/30 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
teleflex.com/usa/investor/index
Company Research
Source: PR Web
PLEASANTON, Calif. (PRWEB) April 01, 2020 NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Michael Belsante M.D., Urology Associates, PC in Nashville, TN, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Belsante has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate. Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure
Show less
Read more
Impact Snapshot
Event Time:
TFX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TFX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TFX alerts
High impacting Teleflex Incorporated news events
Weekly update
A roundup of the hottest topics
TFX
News
- Here's Why Teleflex (TFX) is a Strong Growth Stock [Yahoo! Finance]Yahoo! Finance
- Teleflex Incorporated (NYSE: TFX) had its "hold" rating re-affirmed by analysts at Truist Financial Co.. They now have a $227.00 price target on the stock, down previously from $255.00.MarketBeat
- Teleflex Incorporated (NYSE:TFX) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates [Yahoo! Finance]Yahoo! Finance
- Teleflex Incorporated (NYSE: TFX) had its price target lowered by analysts at Royal Bank of Canada from $275.00 to $245.00. They now have an "outperform" rating on the stock.MarketBeat
- Teleflex Incorporated (NYSE: TFX) had its price target lowered by analysts at Mizuho from $275.00 to $250.00. They now have a "neutral" rating on the stock.MarketBeat
TFX
Earnings
- 10/31/24 - Beat
TFX
Sec Filings
- 10/31/24 - Form 10-Q
- 10/31/24 - Form 8-K
- 8/29/24 - Form 8-K
- TFX's page on the SEC website